B. Braun Medical Inc, a provider of smart infusion therapy and pain management, announces the launch of its new Caresite Micro Luer Access Device, designed to reduce exposure to harmful chemicals and decrease infection risk, making IV access safer for patients and healthcare providers.
The Caresite Micro Device is the only needleless connector not made with Bisphenol A (BPA), a harmful chemical known to cause multi-organ toxicity. Made with a drug-resistant material, the Caresite Micro Device can help reduce the risk of infections and drug exposure resulting from stress cracks associated with material and drug incompatibility.
Hospital-acquired bloodstream infections (HA-BSIs), which are often associated with catheter insertions, remain a major cause of morbidity and mortality. The Caresite Micro Device features a smooth, flat surface that allows proper disinfection, and a straight fluid path design that helps complete flushing of blood and medications with a small flush volume, helping to reduce the risk of HA-BSI.
“We are excited to introduce the Caresite Micro Luer Access Device. Helping to reduce HA-BSIs and accidental drug exposure supports our commitment to the safety of the patients and providers we serve,” says Angela Karpf, MD, corporate vice president, medical affairs.
